|
|
||||||||
J Thorac Cardiovasc Surg 2006;132:435-436
© 2006 The American Association for Thoracic Surgery
Brief Communication |
a Departments of Thoracic and Cardiovascular Surgery, Medical School of Hannover, Hannover, Germany
b Departments of Cardiology and Angiology, Medical School of Hannover, Hannover, Germany
c Department of Pathology, Medical School of Hannover, Hannover, Germany
Received for publication January 14, 2006; accepted for publication February 7, 2006. * Address for reprints: Kalliopi Athanassiadi, MD, Department of Thoracic and Cardiovascular Surgery, Medical School of Hannover, Carl-Neuberg Str. 1, 30627 Hannover, Germany (Email: kallatha{at}otenet.gr).
Primary malignant tumors of the pulmonary artery (PA) are rare with a dismal prognosis despite diagnostic, operative, and oncologic advances.
1
We report 2 cases of primary leiomyosarcoma of PA with a long survival of 7 and 2.5 years including clinical presentation, diagnosis, and surgical treatment.
Material
Case 1
A 61-year-old woman was admitted to our department with suspected chronic pulmonary thromboembolism resulting in a complete occlusion of the right PA.
2
The patient had chest pain followed by a progressive limitation of physical fitness and dyspnea (New York Heart Association classes II and III). Computed tomography (CT) scan revealed a hypodense formation with complete occlusion of the right PA. A lung perfusion-scintigraphy confirmed an almost complete loss of perfusion of the right lung, and a cardiac catheterization showed a mild pulmonary hypertension. Preoperative biopsy revealed sarcoma. After staging with cerebral magnetic resonance imaging and abdomen CT scan, the patient underwent a median sternotomy to right pneumonectomy and partial resection of the right main PA wall under cardiopulmonary bypass and reconstruction with a pericardial patch. The final histologic diagnosis stated leiomyosarcoma of low differentiation (G3) of PA with invasion of the proximal PA resection area (Figures 1 and 2).
Subsequently, the patient underwent a second operation under extracorporeal circulation with complete resection of the PA trunk including the left PA. The reconstruction was performed with a 6-cm polytetrafluoroethylene (Gore-Tex, Flagstaff, Ariz) prosthesis. The postoperative recovery was uneventful. In a follow-up of 7 years, she is alive with no recurrence. Her quality of life and exercise tolerance have improved.
|
|
Discussion
Leiomyosarcomas of the PA are rare mesenchymal tumors with a poor prognosis and a mean survival of 1.5 months if no treatment is administered.
1,2
Only 39 cases have been reported in the literature. Patients have a mean age of 50 years and show an equal distribution of gender.
3
Its intraluminal growth is usual, leading to a progressive obstruction of right ventricular blood flow into the pulmonary circulation and a varying obstruction of pulmonary perfusion, thus resulting in clinically unspecific symptoms of dyspnea, cough, or impaired right ventricular function mimicking pulmonary thromboembolism in the majority of cases.
2-4
The radiologic diagnosis can still be difficult despite the technologic advances in imaging techniques.
1,5
Preoperative biopsy is the only way to establish a proper diagnosis, and it is essential to accurately plan the surgical approach.
5
The only treatment of choice is radical surgical resection.
4
Depending on tumor localization and distal extension, surgical treatment includes PA resection, a polytetrafluoroethylene (Gore-Tex) homograft, or even xenograft reconstruction and pneumonectomy. The use of cardiopulmonary bypass may be essential in patients in whom the tumor originates from the PA trunk or the pulmonary valve. As a palliative treatment, endovascular stent grafting may be an alternative therapeutic option in inoperable cases. Furthermore, neoadjuvant or adjuvant chemotherapy has been mentioned in the literature with doubtful results.
Prolonged tumor-free survival is rare. A 10-month survival is reported in the literature for different sarcomas of PA,
5
whereas in our series survival was 7 and 2.5 years, respectively.
Conclusion
Early diagnosis along with aggressive and extensive surgical treatment in patients with PA leiomyosarcoma without any extrathoracic metastases may provide an opportunity for prolonged survival in addition to palliation.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |